Sbc Medical Group Holdings Incorporated · NASDAQ:SBC
Sbc Medical — Q3 2024 Earnings Presentation
12 slides from Sbc Medical's earnings presentation, Nov 13, 2024
Slide 1: 2024 Third Quarter Financial Highlights
SBC Medical Group toteings, ine 2024 Third Quarter Financial Highlights November 2024
Slide 2: Disclaimer
Disclaimer This presentation contains certain financial measures that are not recognized under generally accepted accounting principles in the United States ("GAAP"), including EBITDA and EBITDA margin. For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP me
Slide 3: 3Q24 YTD Highlights: Growth Across the Board
3Q24 YTD Highlights: Growth Across the Board SBC + Almost all key figures have experienced growth relative to 3Q23 YTD. SBC Medical Group Holdings Key Financials (24Q3 YTD) Franchise Clinics Key Figures Total revenues EBITDA*" EBITDA Margin*? Number of Franchise clinics + Sep24 $1 60m $68m 42% 22 Ac
Slide 4: Revenue Growth Driven by Diverse Services
Revenue Growth Driven by Diverse Services Sroup Holdings, Ine + Revenue has steadily increased in line with the expansion of number of clinics. + Management services decreased mainly by the stop of staffing services. +15.1 +9.6 465 t28 160.9 131.1 2303 Royalty Procurement — Management Rental Others
Slide 5: EBITDA Growth Driven by Top Line
EBITDA*' Growth Driven by Top Line SBC + EBITDA has also been steadily increased. + “Stock-based compensation expenses” is one time expense related to the listing process. (mm us$) +29. +6. 29.8 ina 6.4 — = (1.5) (4.1) ro 422 Co 8) 56.3 23Q3YTD Revenue Cost of Salaries Consulting Stock-based Others
Slide 6: Robust Balance Sheet Positioned for Growth
Robust Balance Sheet Positioned for Growth SBC's balance sheet is strong with ample cash and borrowing capacity. Key Balance Sheet Figures (as of September 30, 2024) Selected items from Balance Sheet Dec 31 June 30, Sep 30, 2023 2024 2024 QoQ Total current assets 165 169 202 +32 USS1 37mn 0.03x Cash
Slide 7: Public Shareholder Driven Capital Policy
SBC Public Shareholder Driven Capital Policy relic or + Shareholder return, growth investment, and building a strong capital base are all important considerations to ensure value creation reflecting our commitment to public shareholders. Shareholder Return * Maximizing SBC’s shareholder value with r
Slide 8: Appendix
SBC Appendix SBC Medical Group Holdings, Inc.
Slide 9: Income Statement (Consolidated)
SBC Income Statement (Consolidated) ree ie Income Statemer Operating Expenses FY23 233 | 2403 2303 2403 2303 | 2403 (mm US$) YTD YTD | YTD % YoY Tne || Sap YoY Total revenues 193 131 160 +23% 47 83 +12% Total operating expenses 47-56 420% Royalty income 42 25 = 45 -+79% 8 15 +82% Salaries and welfar
Slide 10: Balance Sheet (Consolidated)
Balance Sheet (Consolidated) erin fire (mm US$) 2023 2024 2024 (mm uss) 2023 2024 Total asets oe Total bites va) ae Total current assets +32 Total current liabilities 92 Cash and cash equivalent 103 103 137 +33 Accounts payable 26 14 14 +0 on ReceWableselatca 33 23 27 43 Notes payable -related parti
Slide 11: Cash Flows (Consolidated)
Cash Flows (Consolidated) SBC FY23 | 2393 | 2493 (mm US$) YTD YTD YTD % YoY Net cash provided by operating activities 50 22 27 =+23% Net cash provided by (used in) investing activities il 8 (5) (164)% Net cash provided by financing activities 6 6 11 +85% Effect of changes in foreign currency exchang
Slide 12: Reconciliation Table on Non-GAAP Financials
Reconciliation Table on Non-GAAP Financials SBC 23Q3 24Q3 23Q3 24Q3 (mmUS$)__ YTD YTD (A) Total Revenues 131 160 47 53 (B) Income from operations 46 65 20 13 Depreciation and amortization (C) expense 9 2 3 1 (D) =(B)+(C) EBITDA 56 68 23 14 (E) =(D)/(A)__ EBITDA Margin 43% 42% 49% 28% SBC Medical Gro
SBC Medical Group Holdings — Q3 2024 Earnings Presentation on 6ix